Vascular endothelial growth factor-A: a multifunctional molecular player in diabetic retinopathy.
about
Fingolimod Associated Bilateral Cystoid Macular Edema-Wait and See?Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathyDiabetic macular edema: new concepts in patho-physiology and treatment.Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathyEndoglin promotes angiogenesis in cell- and animal-based models of retinal neovascularization.Pathophysiology and treatment of diabetic retinopathy.Expression and characterization of a soluble VEGF receptor 2 proteinCost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspective.Vascular Endothelial Growth Factor and Diabetic Retinal Disease.Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab.Neuropilin 1 Involvement in Choroidal and Retinal Neovascularisation.Hypoxic retinal Muller cells promote vascular permeability by HIF-1-dependent up-regulation of angiopoietin-like 4.Emerging therapeutic approaches in the management of retinal angiogenesis and edema.Inflammation in diabetic retinopathy.Effect of cilostazol in treating diabetes-associated microvascular complications.Induction of ischemic tolerance protects the retina from diabetic retinopathy.VIP protects human retinal microvascular endothelial cells against high glucose-induced increases in TNF-α and enhances RvD1.Vascular endothelial growth factor in the ischemic retina and its regulation by somatostatin.Comparative transcriptional profiling analysis of the effect of heat waves during embryo incubation on the hatchlings of the Chinese soft-shelled turtle (Pelodiscus sinensis).Change of ranibizumab-induced human vitreous protein profile in patients with proliferative diabetic retinopathy based on proteomics analysis.A review of the multifunctionality of angiopoietin-like 4 in eye disease
P2860
Q28068032-D8D87488-9CA8-4860-8945-36E942F47E8CQ28262797-8A397C5B-B188-4AE5-81C5-6FFE0B84FCD9Q33713517-4D0A629C-4857-4BCD-AE36-CCE92E83D79FQ34005734-64FA286B-9932-422B-A408-42DFA83C0CFCQ34341837-2CEED7BF-7C8A-4C10-A08B-D7B9194EBB05Q34528134-EE2521E9-75B5-411B-BDBF-25241482C511Q35117417-3DE12B9F-91E3-449B-BD1F-853C949F8059Q35592307-E27A05EA-177C-49CB-A9AD-CBA44AF5DFC4Q35950867-116B4D9A-B2E0-41B6-8615-1375785B03A4Q36079348-3C59BCA7-3666-429B-A01B-0C14FD0ED739Q36255703-73A42878-B37C-46CF-9055-7F2A2AEC837FQ37157321-38E036B8-0E48-4920-97D5-EB8A03BEF6E3Q37822290-B6FDD102-AF39-4BA8-B80A-60B4EFB69DB9Q37884176-9E3F6923-B0ED-43C6-B950-488E52EC4961Q39178804-7BD30BF3-093F-4327-92CB-96C4E6B4C2D1Q42045075-C84BEE89-CC84-4E3C-9FC3-B0A4C62B0B69Q42329973-8A320F93-FD30-4959-B6F1-680A674539ACQ44123560-5FAAA0D9-68EB-4B5B-81E5-D9C4C94F0BC8Q53692224-EA3D13A6-6D79-4E6D-828D-D45ED9C1C046Q54965847-DFBDEE72-A058-4962-98C9-5191E685636EQ57157493-E39F6273-4A53-4867-8EB9-881A0647B7F8
P2860
Vascular endothelial growth factor-A: a multifunctional molecular player in diabetic retinopathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Vascular endothelial growth fa ...... layer in diabetic retinopathy.
@en
Vascular endothelial growth fa ...... layer in diabetic retinopathy.
@nl
type
label
Vascular endothelial growth fa ...... layer in diabetic retinopathy.
@en
Vascular endothelial growth fa ...... layer in diabetic retinopathy.
@nl
prefLabel
Vascular endothelial growth fa ...... layer in diabetic retinopathy.
@en
Vascular endothelial growth fa ...... layer in diabetic retinopathy.
@nl
P2093
P1476
Vascular endothelial growth fa ...... layer in diabetic retinopathy.
@en
P2093
Brett D Hambly
Mark C Gillies
Shisan Bao
Xinyuan Zhang
P304
P356
10.1016/J.BIOCEL.2009.07.011
P577
2009-07-29T00:00:00Z